European Regulators Warn Of Anemia Drug Risks
The recommendation, announced Thursday by the European Medicines Agency, applies to drugs containing the chemical epoetin. These drugs, known as erythropoiesis-stimulating agents, include Amgen Inc.'s Aranesp and Johnson & Johnson subsidiary Ortho Biotech Products LLP's Eprex, sold in the U.S. as Procrit.
ESAs are commonly used to treat anemia caused by chemotherapy and HIV medications....
To view the full article, register now.